News | Modern Healthcare

340B Supporters Cope with Mounting Criticism of Expanded Program

June 26, 2015

A recent article refers to an analysis conducted by Aaron Vandervelde regarding drug purchases and 340B trends, prices, and projections.

Read the article.

Find out more about the 340B study, Growth of the 340B Program.



Related Professionals

Aaron Vandervelde

Managing Director

Washington, DC